Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
GOLDMAN SACHS GROUP INC
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 03/31/2023 | Revance Therapeutics, Inc. | RVNC | 1,098,290 | -41,518 | 35,375,921,000 | 35,345,147,000 | $32,210.00 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 1,139,808 | 310,883 | 30,774,000 | 19,318,000 | $27.00 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 828,925 | 22,893 | 11,456,000 | -1,699,000 | $13.82 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 806,032 | 211,332 | 13,155,000 | -3,413,000 | $16.32 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 594,700 | 129,264 | 16,568,000 | 2,772,000 | $27.86 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 465,436 | 61,310 | 13,796,000 | 2,344,000 | $29.64 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 404,126 | -48,490 | 11,452,000 | 73,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 452,616 | -108,259 | 11,379,000 | -2,317,000 | $25.14 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 560,875 | -170,659 | 13,696,000 | 2,869,000 | $24.42 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 731,534 | 623,626 | 10,827,000 | 9,076,000 | $14.80 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 107,908 | 33,193 | 1,751,000 | 780,000 | $16.23 |
| 09/30/2019 | Revance Therapeutics, Inc. | RVNC | 74,715 | 21,030 | 971,000 | 275,000 | $13.00 |
| 06/30/2019 | Revance Therapeutics, Inc. | RVNC | 53,685 | -58,773 | 696,000 | -1,076,000 | $12.96 |
| 03/31/2019 | Revance Therapeutics, Inc. | RVNC | 112,458 | 72,996 | 1,772,000 | 978,000 | $15.76 |
| 12/31/2018 | Revance Therapeutics, Inc. | RVNC | 39,462 | -43,908 | 794,000 | -1,278,000 | $20.12 |
| 09/30/2018 | Revance Therapeutics, Inc. | RVNC | 83,370 | -52,872 | 2,072,000 | -1,667,000 | $24.85 |
| 06/30/2018 | Revance Therapeutics, Inc. | RVNC | 136,242 | 109,696 | 3,739,000 | 2,790,000 | $27.44 |
| 12/31/2017 | Revance Therapeutics, Inc. | RVNC | 26,546 | -158,334 | 949,000 | -4,144,000 | $35.75 |
| 09/30/2017 | Revance Therapeutics, Inc. | RVNC | 184,880 | 5,223 | 5,093,000 | 350,000 | $27.55 |
| 06/30/2017 | Revance Therapeutics, Inc. | RVNC | 179,657 | -368,993 | 4,743,000 | -6,669,000 | $26.40 |
| 03/31/2017 | Revance Therapeutics, Inc. | RVNC | 548,650 | 141,400 | 11,412,000 | 2,982,000 | $20.80 |
| 12/31/2016 | Revance Therapeutics, Inc. | RVNC | 407,250 | -18,375 | 8,430,000 | 1,530,000 | $20.70 |
| 09/30/2016 | Revance Therapeutics, Inc. | RVNC | 425,625 | 425,625 | 6,900,000 | 6,900,000 | $16.21 |
| 06/30/2016 | Revance Therapeutics, Inc. | RVNC | 425,179 | 125,123 | 5,782,000 | 543,000 | $13.60 |
| 03/31/2016 | Revance Therapeutics, Inc. | RVNC | 300,056 | -15,770 | 5,239,000 | -5,549,000 | $17.46 |
| 12/31/2015 | Revance Therapeutics, Inc. | RVNC | 315,826 | -65,659 | 10,788,000 | -565,000 | $34.16 |
| 09/30/2015 | Revance Therapeutics, Inc. | RVNC | 381,485 | 71,547 | 11,353,000 | 1,441,000 | $29.76 |
| 06/30/2015 | Revance Therapeutics, Inc. | RVNC | 309,938 | -106,027 | 9,912,000 | 1,289,000 | $31.98 |
| 03/31/2015 | Revance Therapeutics, Inc. | RVNC | 415,965 | 415,965 | 8,623,000 | 8,623,000 | $20.73 |
| 12/31/2014 | Revance Therapeutics, Inc. | RVNC | 402,755 | -22,690 | 6,823,000 | -1,401,000 | $16.94 |
| 09/30/2014 | Revance Therapeutics, Inc. | RVNC | 425,445 | -14,257 | 8,224,000 | -6,726,000 | $19.33 |
| 06/30/2014 | Revance Therapeutics, Inc. | RVNC | 439,702 | 196,599 | 14,950,000 | 7,292,000 | $34.00 |
| 03/31/2014 | Revance Therapeutics, Inc. | RVNC | 243,103 | 243,103 | 7,658,000 | 7,658,000 | $31.50 |
| << Prev Next >> |
|